Centene Corporation (CNC) and Molina Healthcare (MOH) stand out as leading pure-play managed care organizations centered on government-sponsored programs, especially Medicaid. With most of their revenue tied to state and federal contracts, the two are often compared by investors looking for exposure to this sector. This comparison matters when balancing factors like company scale versus specialized focus, near-term momentum versus longer-term earnings potential, and varying risk levels in the same regulatory setting. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Centene Corporation is the largest Medicaid managed care company in the United States, with substantial operations in Medicare, Health Insurance Marketplace, and commercial lines. Its scale shows in a market capitalization near $36 billion and annual revenue approaching $190 billion. In recent weeks, CNC has stood out among peers, climbing sharply year to date and recovering strongly from its 52-week low after earlier pressure from elevated medical costs and withdrawn guidance.
Recent results have supported a clearer earnings path. The latest quarterly numbers beat expectations, and management raised full-year adjusted earnings guidance. Its health benefits ratio has improved, pointing to better cost control. A series of analyst price-target increases, along with positive policy signals around Medicaid and Affordable Care Act funding, has added to the stock’s momentum.
Molina Healthcare focuses on low-income individuals and families, with Medicaid making up roughly 71% of revenue and the rest split between Medicare and Marketplace. It remains much smaller than CNC, with a market capitalization near $11 billion. In recent weeks, MOH has also moved higher, though its story reads more as a recovery than a momentum play.
Membership has slipped modestly year to date, and operating margins stay thin amid elevated medical costs and startup expenses for new contracts such as the Florida program. Management has kept full-year guidance intact and outlined a route to meaningfully higher earnings in 2027, pointing to improving Medicaid rate cycles and embedded earnings power. This longer-term view has attracted some interest, even as near-term results face more pressure than those at its larger peer.
The clearest difference lies in scale. CNC runs a diversified, multi-segment platform with far larger revenue and membership, while MOH operates a more focused, Medicaid-heavy model. This leads to different drivers: Centene’s recent gains stem from margin repair across a broad book, whereas Molina’s case rests on a multi-year earnings recovery tied to rate normalization and new contract execution.
On momentum, CNC has been the stronger relative performer, with better year-to-date gains and rising analyst targets. MOH carries a higher forward earnings multiple and contends with membership attrition from eligibility redeterminations and work requirements. Both share sector risks such as regulatory shifts, medical cost inflation, and policy uncertainty, yet Molina’s smaller size and thinner current margins leave it more exposed to execution issues.
Considering trend consistency, momentum, stability, and relative positioning, Tickeron’s AI points toward CNC in the current environment. The stock’s mix of better medical cost ratios, raised earnings guidance, broader analyst support, and stronger recent performance creates a more consistent trend profile than MOH, where the outlook hinges more on future recovery. Both could gain from a steadier Medicaid rate cycle, but Centene’s larger scale and firmer near-term fundamentals currently offer a more balanced risk-reward setup from a momentum standpoint.
In my research process, I frequently review Tickeron’s Trending AI Robots to identify automated strategies that align with current market conditions. These bots cover a wide range of styles and timeframes, helping to surface quantitative approaches that complement fundamental comparisons like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for MOH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 52 cases where MOH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on MOH as a result. In 57 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
MOH moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOH advanced for three days, in 215 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 148 of 222 cases where MOH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
The 10-day RSI Indicator for MOH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 18 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Moving Average Convergence Divergence Histogram (MACD) for MOH turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
MOH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating fairly steady price growth. MOH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.616) is normal, around the industry mean (3.520). MOH's P/E Ratio (1306.188) is considerably higher than the industry average of (126.353). Projected Growth (PEG Ratio) (0.880) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.233) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of health care services to persons eligible for Medicaid
Industry ManagedHealthCare